Edgewise Therapeutics, Inc.

17.47 USD
+0.66 (+3.93%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Edgewise Therapeutics, Inc. stock is down -3.91% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 June’s closed higher than May. In the last 1 Unusual Options Trades, there were 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Jun 18:36 16 Aug, 2024 17.50 CALL 75 175

About Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy.